Carbazeran

This classification denotes a phosphodiesterase inhibitor with the molecular formula C18H24N4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0N4I6K95P2, chemically known as 1-(6,7-dimethoxy-1-phthalazinyl)-4-piperidyl ethylcarbamate but generally known as carbazeran, which bears US NIH Compound Identifier 71983. European Medicines Agency schedules Carbazeran in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06118MIG. The term CARBAZERAN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 35, No. 5 1981, List 21). CARBAZERAN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule carbazeran under HS 29333999 and SITC 51574. As of Q4 2014, CARBAZERAN remains the US FDA Preferred Term for this commodity. Carbazeran bears US NLM identifiers UMLS ID C0054655 and NCI Concept Code C76027. SMILES: O(C1CCN(CC1)C1NNCC2C1CC(OC)C(OC)C2)C(=O)NCC.